ERDMANN DESIGN

HUMAN CENTERED DESIGN
SWITZERLAND

YES!
WE UNDERSTAND YOU.

INVESTORS

INVESTORS

Today life science investments are in high demand. Erdmann Design takes a vital role in life science investments: Through active involvement early in the product and service development process we spark start-up companies’ early growth.

MEDICAL

MEDICAL

Medical doctors and life science experts are seeking to bring their own product ideas to the market. The patient is their focus: Doctors and other experts address the patient’s complete health experience not just their symptoms.

EXECUTIVE

EXECUTIVE

Swiss industrial partners strive for high manufacturing quality as well as clinical efficacy in their work. As an innovation partner we collaborate to find solutions, including solving regulatory issues. We build a reliable design and production network to bring the product from idea to realisation.

EXPERTS

EXPERTS

Success in medical design, engineering and manufacturing teams requires experienced project leaders. Our goal: Synthesizing experience and creating opportunities for the company. 

USERS

USERS

In addition to ease of use, clinical efficacy and safety, we designers are looking for the good solution. This solution lowers costs and provides patient satisfaction. 

«Erdmann Design’s active involvement early in the product and service development process is an absolute benefit for Naviswiss. Erdmann creates intelligent medical products and drives innovation.»

Christian Walsoe, CFO, Member of the board, Naviswiss AG, Switzerland

Mindmap

NAVISWISS

New Navigated Surgery  
Switzerland

UNDERSTANDING THE DESIGN CONTEXT

What users believe they know about a product strongly impacts how they use it. A mental model is based on belief, not facts.


Designing for others means drawing on knowledge of mental models and requires entering users‘ understanding.

Raimund Erdmann

«I was surprised to find out how similar the design process is to the patient history and documentation which we surgeons use to exchange experiences among each other. Since then we have worked together with designers.»

Prof. Dr. Hans-Florian Zeilhofer, Founder Mininavident AG

Mindmap

DENACAM 
3D realtime navigation system for implantology
by Mininavident AG Switzerland

ON THE LEVEL OF USE 

The aim of design is to encourage interfaces that move effortlessly from recognition, to exploration, to reliance, until the user is satisfied.


Affordings include direct perceptions: bendability, twistability, pushability, rotatability, graspability, steerability, heaviness, and danger.


Affordances are irreducible cultural habits and difficult to modify. Designers should make them easily recognizable and bring forth the consequences that users expect, ideally without unnecessary constraints.

Raimund Erdmann

«The creative impulses of the Erdmann Design Team are crucial for our success. They think up surprising solutions!»

Ueli Breitschmid, Owner and CEO Curaden AG, Switzerland

Mindmap

CURAPROX  
HYDROSONIC ORTHO
Hydrodynamic sonic toothbrush

MULTISENSORY REDUNDANCY

The design of products and interfaces must assure that all senses are accounted for.


In designing a product, attention to all senses provides the end-user with a richer experience.


Our process includes testing within the context of use. Testing a product in a real-life light and acoustic situation is crucial to the understanding of the user’s behavior and interaction.

Raimund Erdmann

«Humans learn all the time. Meanings change in use. Users should be able to enter the interface of a system on any skill level and advance their competencies at their own pace. Users should also be permitted to introduce variations on successful scenarios, finding shortcuts, economizing efforts, and having fun.

Stryker’s navigation must acknowledge what users know today, but be designed for learnability.»

Project team leader at Stryker

Mindmap

STRYKER   
PROFESS Navigation System
Pattern Recognition Optics for Functional 
Endoscopic Sinus Surgery

ROBUST SYSTEM

An ideally robust system in one in which most foreseeable mishaps are prevented. When something unintended does slip through, it provides an opportunity for learning something new.


It is a challenge for designers to anticipate what the users of a product might do and provide the necessary clues to prevent interfaces from being disrupted, or worse, causing harm.


Early prototyping with input from medical disciplines and end-users make risks visible, understandable and solvable.

Raimund Erdmann

«Data availability is growing at an exponential rate. Data for patients, for physicians, and for manufacturers. As an industry, we have to get better at using that fragmented data to its full potential by integrating it into new therapeutic concepts to improve outcomes for patients. At the same time, we need to ensure we comply fully with data-privacy law and regulations.»

Cédric Gysel, Human Centered Design Innovation Lab & Make Space Switzerland

Mindmap

JANSSEN    
Practice injecting with this reusuable training device. by Cilag, Janssen  
Switzerland

INTERACTION FEEDBACK

Feedback on any user action should be as immediate and as direct as possible.

Usability workshops with stakeholders to validate the systems interfaces and interactions will give us the necessary relevance to the task.

Raimund Erdmann

Go to article: Home | The dengue dilemma Go to article: In this issueGo to article: Owen MumfordGo to article: ContentsGo to article: Hapa Company Insight Go to article: Daiichi JitsugyoGo to article: NewsGo to article: EmbocapsGo to article: HOF Sonderanlagenbau Company Insight Go to article: HOF SonderanlagenbauGo to article: The pharma industry briefingGo to article: Dow Europe Company InsightGo to article: Gerteis Company InsightGo to article: GerteisGo to article: The problem of manipulated data Go to article: Capsugel Company Insight Go to article: CapsugelGo to article: Timeline: the dengue vaccine dilemmaGo to article: TSS Company Insight Go to article: TSSGo to article: From evergreening to thicketing: exploring manipulation of the pharma patent sysGo to article: Emirates SkyCargoGo to article: AtoZ-CRO Company InsightGo to article: AtoZ-CROGo to article: A safer ride: the latest innovation in targeted cancer treatment Go to article: Swiss WorldCargoGo to article: Accurate BiometricsGo to article: Accurate Biometrics Company Insight Go to article: Nelson LabsGo to article: Treading the line: the challenge of transplant rejection drugsGo to article: Corbion PuracGo to article: Erdmann Design Company InsightGo to article: Erdmann Design SwitzerlandGo to article: Treating menopause: at last a non-hormonal alternative? Go to article: YourwayGo to article: ImmuMap Company Insight Go to article: ImmuMapGo to article: Drug repurposing: the industry’s all-rounder medicinesGo to article: FargoGo to article: Pharma Support Services Company InsightGo to article: Pharma Support ServicesGo to article: One step closer to a Chlamydia vaccine Go to article: AralabGo to article: Synex SyntheticsGo to article: Deals in brief powered by GlobalDataGo to article: Charles Ischi Go to article: The key list powered by GlobalDataGo to article: Pharmaceutical Solutions IndustryGo to article: Clinichain Company Insight Go to article: ClinichainGo to article: SanofiGo to article: EventsGo to article: NymiGo to article: Modality SolutionsGo to article: PfanstiehlGo to article: Next issueGo to article: MimotopesGo to article: ICCI - International Cannabis and Cannabinoids Institute Go to article: ICCI